elisa
perform
test
bind
sensit
recogn
dosedepend
manner
graph
concentr
absorb
nm
hyperbol
curv
fig
western
blot
analysi
show
could
specif
recogn
fig
reaction
seen
neg
control
immunoprecipit
perform
use
could
split
activ
use
trypsin
protein
kda
detect
sdspage
sequenc
match
b
anthraci
protect
antigen
swissprot
databas
fig
c
kda
membran
protein
also
detect
use
commerci
antipa
antibodi
fig
protein
reaction
antibodi
equilibrium
dissoci
constant
kd
determin
analysi
rate
constant
kon
koff
evalu
directli
sensogram
kd
also
determin
use
one
strike
featur
slow
rate
may
explain
high
affin
fig
abil
protect
letx
assess
cell
differ
concentr
lf
simultan
ad
cell
cell
viabil
test
result
indic
could
complet
neutral
letx
lf
cell
remain
viabl
control
igg
antibodytr
cell
remain
viabl
lf
cell
viabl
fig
control
cell
rat
inject
antibodi
via
tail
vein
either
letx
inject
surviv
time
group
iii
significantli
p
longer
group
ii
last
observ
group
iv
rat
aliv
fig
rat
inject
min
letx
show
similar
result
dose
antibodi
protect
rate
death
fig
although
symptom
acceler
breath
lethargi
observ
one
rat
inject
letx
administr
protect
rat
develop
anthrax
fig
prophylact
function
test
inject
antibodi
differ
time
letx
inject
group
receiv
prophylaxi
min
h
letx
inject
rat
remain
aliv
fig
inject
pa
protect
rat
anthrax
death
regardless
lf
inject
time
fig
lung
rat
patholog
immunohistochem
examin
h
e
stain
show
local
tissu
rat
inject
letx
show
greater
alveolar
exud
fig
untreat
control
rat
fig
howev
group
receiv
letx
fig
show
signific
differ
untreat
control
rat
sinc
anthrax
receptor
express
cell
includ
alveolar
epitheli
cell
cell
bind
pa
could
posit
rat
inject
letx
cell
could
dectect
pa
posit
stain
mainli
local
membran
strong
posit
reaction
found
group
inject
letx
fig
weak
posit
reaction
found
group
inject
letx
fig
untreat
control
group
show
neg
reaction
fig
studi
reveal
two
major
find
first
humanmurin
chimer
antibodi
neutral
letx
vivo
use
prohylaxi
letx
releas
blood
second
sinc
immun
produc
neutral
antibodi
use
immun
anim
present
studi
develop
four
murin
mab
could
well
neutral
letx
vitro
one
clone
select
form
humanmous
chimer
antibodi
known
antibodi
show
excel
neutral
vitro
vivo
current
statu
therapeut
mab
direct
major
virul
factor
pa
lf
ef
capsul
although
lf
could
induc
cell
death
effect
result
vivo
unsatisfactori
pa
critic
factor
recogn
cell
membran
receptor
pa
cleav
activ
furin
induc
lf
ef
cell
strategi
get
antibodi
activ
immun
mice
use
form
dissoci
instead
although
part
factor
may
differ
structur
expos
lf
efbind
site
differ
may
turn
lead
product
complet
differ
antibodi
anthrax
vivo
present
studi
show
could
induc
neutral
antibodi
proven
vitro
vivo
experi
hand
difficult
obtain
activ
base
present
method
screen
posit
clone
activ
differ
way
base
tradit
elisa
coat
plate
aliv
cell
overninght
cell
cultur
condit
ad
well
incub
h
neg
control
cell
without
ad
rest
elisa
procedur
normal
screen
system
activ
close
vivo
state
could
oligomer
heptam
divers
antibodi
gener
immun
stage
effect
antibodi
obtain
screen
system
anthrax
whether
result
natur
bioterroristassoci
exposur
constant
threat
human
low
incid
anthrax
suggest
largescal
vaccin
may
effici
mean
control
diseas
passiv
immun
protect
antibodi
therefor
consid
primari
avail
biodefens
especi
bioterroristassoci
exposur
present
studi
found
provid
good
protect
rat
challeng
anthrax
virul
factor
vitro
experi
maintain
cell
viabil
lf
noncorrel
igg
maintain
cell
viabil
lf
maintain
cell
viabil
control
antibodi
maintain
moreov
previou
studi
often
use
rat
challeng
letx
tabl
test
b
anthraci
spore
therefor
rat
inject
letx
vial
tail
vain
kd
nm
protect
rat
death
concentr
mgkg
per
rat
howev
previou
studi
mgkg
raxibacumab
human
origin
kd
nm
administ
h
anthrax
lethal
toxin
administr
also
test
concentr
mgkg
per
rat
administ
h
letx
inject
dose
also
protect
rat
find
indic
may
use
prophylact
human
chimer
mab
examin
anim
model
affin
found
present
studi
better
found
murin
mab
pa
develop
chimer
mab
maintain
balanc
highaffin
murin
compon
lowimmunogen
human
compon
mab
human
origin
avail
difficult
produc
chimer
mab
produc
cell
method
product
conveni
vivo
test
present
studi
irrespect
whether
lf
inject
antibodi
protect
rat
death
provid
administ
simultan
pa
find
indic
could
prevent
lf
bind
morpholog
chang
observ
rat
inject
letx
probabl
time
inject
sacrific
short
min
histolog
chang
occur
period
ihc
analysi
show
strong
posit
result
group
inject
letx
howev
group
receiv
letx
show
weakli
posit
reaction
find
indic
prevent
pa
bind
cell
receptor
howev
experi
requir
valid
hypothesi
futur
studi
focu
detail
character
mab
specif
toxic
studi
autoantigen
test
etc
second
epitop
map
structur
function
analysi
perform
vivo
experi
present
studi
demonstr
could
interfer
lf
bind
pa
experiment
need
determin
exact
mechan
neutral
letx
lastli
anim
test
requir
exampl
anim
challeng
anthrax
spore
summari
report
humanmurin
chimer
igg
name
specif
identifi
pa
high
affin
neutral
letx
protect
macrophag
rat
anthraxrel
death
also
show
good
immunogen
find
believ
character
use
alon
combin
neutral
mab
treatment
anthrax
recombin
protein
express
escherichia
coli
use
pcoldii
vector
purifi
affin
chromatographi
six
balbc
mice
age
week
intraperiton
ip
immun
adjuv
describ
immun
mous
spleen
show
best
titer
remov
splenocyt
extract
fuse
myeloma
cell
use
hybridoma
posit
clone
screen
elisa
use
activ
plate
subclon
conduct
base
standard
protocol
clonal
expans
conduct
hybridomasfm
gibco
usa
cell
supernat
remov
purifi
affin
chromatographi
protein
g
ge
usa
accord
manufactur
purif
system
experi
involv
anim
perform
accord
protocol
approv
anim
care
use
committe
nation
institut
allergi
infecti
diseas
nation
institut
health
usa
total
rna
extract
hybridoma
cell
use
trizol
reagent
invitrogen
cdna
synthes
use
revers
transcriptas
superscript
ii
accord
manufactur
instruct
eukaryot
vector
construct
separ
clone
heavi
light
variabl
region
pth
ptl
respect
includ
constant
region
heavi
light
chain
murin
variabl
region
heavi
vh
light
chain
vl
first
amplifi
pcr
use
cdna
templat
obtain
vh
vl
nucleotid
sequenc
chain
clone
vector
pcr
primer
design
use
infusionr
hd
clone
kit
clontech
vh
vl
amplifi
rightsequenc
vector
use
primer
final
vh
vl
separ
clone
linear
pth
ptl
vector
respect
infus
pcr
use
infusionr
hd
clone
kit
recombin
vh
vl
vector
sequenc
genescript
sequenc
analyz
use
databas
http
recombin
vector
simultan
transfect
cell
use
express
system
invitrogen
six
day
transient
transfect
cell
supernat
harvest
purifi
affin
chromatographi
protein
ge
usa
accord
manufactur
purif
system
puriti
chimer
antibodi
examin
sdspage
coomassi
blue
stain
ninetysixwel
enzym
immunoassay
plate
coat
overnight
antigen
dilut
mm
sodium
carbon
buffer
ph
plate
block
serial
twofold
dilut
ad
well
well
concentr
primari
antibodi
plate
incub
h
wash
time
pb
contain
tween
pbst
subsequ
goat
antihuman
conjug
sigma
ad
secondari
antibodi
incub
min
color
develop
absorb
valu
well
detect
nm
noncorrel
use
control
absorb
valu
nm
plot
use
graphpad
prism
softwar
version
graphpad
softwar
inc
la
jolla
ca
usa
cell
lysat
recombin
bacteria
e
coli
separ
run
sdspage
gel
transfer
onto
nitrocellulos
membran
biorad
membran
block
pb
contain
dri
milk
overnight
incub
h
rt
dilut
mgml
stock
wash
time
pbst
membran
incub
dilut
secondari
hrpconjug
goat
antihuman
antibodi
sigma
addit
min
rt
follow
wash
procedur
signal
detect
use
ecl
western
blot
substrat
pierc
accord
manufactur
instruct
mixtur
prepar
incub
mm
tri
ph
mm
nacl
trypsin
sigma
min
follow
addit
soybean
trypsin
inhibitor
sigma
mixtur
incub
rotat
h
next
proteina
sepharos
invitrogen
usa
ad
incub
immun
complex
form
wash
time
pbst
subsequ
elut
buffer
ad
separ
antibodyantigen
complex
proteina
sepharos
neg
control
anoth
chimer
antibodi
gener
lab
creat
use
protocol
protein
complex
isol
run
two
sdspage
gel
one
transfer
onto
nitrocellulos
membran
stain
coomassi
blue
nitrocellulos
membran
block
overnight
incub
dilut
rabbit
polyclon
antipa
antibodi
pierc
usa
h
rt
wash
pbst
time
react
dilut
goat
antirabbit
igghrp
conjug
sigma
addit
min
rt
membran
wash
time
pbst
hybrid
signal
detect
use
ecl
western
blot
substrat
target
band
sdspage
gel
subject
mass
spectra
identif
abi
proteom
analyz
malditoftof
mass
spectromet
appli
biosystem
framingham
mass
spectra
search
within
swissprot
databas
use
mascot
search
engin
http
wwwmatrix
sciencecom
matrix
scienc
uk
biacor
system
ge
usa
use
analyz
affin
kinet
antibodi
dilut
acet
buffer
mm
naac
ph
immobil
surfac
sensor
chip
ge
usa
captur
purifi
mab
dilut
run
buffer
mm
hepe
mm
nacl
mm
ph
achiev
differ
concentr
rang
nmoll
associ
time
set
dissoci
time
follow
regener
mm
ph
sensogram
evalu
use
biacor
evalu
softwar
vitro
letx
neutral
assay
perform
describ
briefli
murin
macrophag
cell
cultur
dmem
contain
fetal
bovin
seru
penicillinstreptomycin
seed
plate
confluenc
lf
dilut
serial
complet
medium
contain
pa
mixtur
appli
cell
well
dilut
follow
final
concentr
lf
ngml
pa
plate
incub
h
untreat
cell
cell
treat
letx
act
control
cell
viabil
determin
use
aq
assay
promega
mi
accord
manufactur
instruct
vivo
letx
neutral
assay
perform
use
femal
fischer
rat
weigh
g
everi
rat
group
n
inject
via
tail
vein
mixtur
pa
lf
letx
differ
amount
antibodi
prepar
steril
pb
rat
administ
mixtur
rat
also
treat
differ
concentr
antibodi
min
exposur
letx
experi
inject
intraven
pb
antibodi
receiv
intraven
inject
letx
pa
lf
addit
doubl
complet
protect
dose
antibodi
inject
test
prophylact
abil
rat
inocul
antibodi
follow
letx
administr
differ
time
min
h
two
addit
experi
conduct
rat
one
group
receiv
pa
inject
min
lf
respect
receiv
pa
min
lf
dose
inject
letx
sign
malais
death
check
everi
min
first
h
h
h
follow
twicedaili
check
week
lung
rat
embed
paraffin
wax
depart
patholog
nanj
medic
univers
jiangsu
china
use
routin
method
section
deparaffin
xylen
dehydr
decreas
concentr
alcohol
section
treat
h
e
stain
examin
light
microscopi
determin
patholog
featur
lung
tissu
remain
section
endogen
peroxidas
activ
block
incub
hydrogen
peroxidas
trisbuff
salin
tissu
section
incub
rabbit
polyclon
antipa
primari
antibodi
pierc
usa
follow
envis
hrp
complex
dako
carpinteria
ca
counterstain
hematoxylin
qs
vector
laboratori
burlingam
ca
result
analyz
accord
ihc
score
ih
describ
briefli
ih
determin
evalu
stain
densiti
intens
multipl
intens
percentag
score
yield
final
ih
sampl
ih
consid
weakli
posit
ih
consid
strongli
posit
ihc
result
evalu
two
independ
investig
blind
rat
group
case
conflict
pathologist
review
case
consensu
reach
kaplan
meier
analysi
use
evalu
surviv
surviv
data
analyz
use
graphpad
prism
version
statist
analysi
softwar
san
diego
ca
ttest
use
compar
mean
surviv
time
group
twotail
log
rank
test
use
determin
statist
signific
differ
group
p
valu
consid
statist
signific
cite
articl
xiong
et
al
novel
chimer
antipa
neutral
antibodi
postexposur
prophylaxi
treatment
anthrax
sci
rep
doi
